Close Menu

The New York Times reports on concerns in the biomedical community about what to do as our ability to detect tumors improves -- to the point where even the slightest number of cancerous cells will send up the alarm. As genomic tests advance, sensitivity will only increase -- but what does that mean for patients who may be treated for cancer when really they're quite healthy? From the article:

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.